Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways.
Saved in:
| Title: | Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways. |
|---|---|
| Authors: | Chiang CY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Hsieh MS; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Chen MY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Tsai YW; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Lin CL; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Hsu CW; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Yu GY; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan., Huang MH; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan., Liu SJ; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan., Chen HW; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. |
| Source: | Theranostics [Theranostics] 2026 Jan 01; Vol. 16 (5), pp. 2342-2356. Date of Electronic Publication: 2026 Jan 01 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
